Genmab — Juni 2024
-
og tak i lige måde JKY
-
Genmab klar med friske data - analytiker kalder dem 'imponerende' https://www.euroinvestor.dk/nyheder/genmab-klar-med-friske-data-analytiker-kalder-dem-imponerende (not sure if it was posted already)
-
Hvis nogen skulle være i tvivl. - Så kan vi vel godt konstatere nu at aktien er "syg".... Og der er kun en modgift, og det er en opt in på Superdara alt andet positivt info, bliver absorberet og solgt ud på..... Og føj, hvor kunne det godt se ud til at det bliver et grimt halvår vi går i møde

-
Monforte..Vidunderligt at høre. Tak for update.

-
TECVAYLI
(teclistamab-cqyv) shows sustained deep and durable responses in patients with relapsed or refractory multiple myeloma https://www.jnj.com/media-center/press-releases/tecvayli-teclistamab-cqyv-shows-sustained-deep-and-durable-responses-in-patients-with-relapsed-or-refractory-multiple-myeloma#:~:text=CHICAGO (June 3%2C 2024),and who previously received three -
Tillykke Monforte, håber det fortsætter på samme vis
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind